K-numberK243218
Device nameTBS iNsight (V4)
ApplicantMedimaps Group SA
Product codeKGI
Device classClass II
Decision dateJan 17, 2025
DecisionSubstantially Equivalent
Regulation892.1170
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

TBS iNsight (V4) is software that analyzes DXA (dual energy X-ray absorptiometry) spine images to calculate a Trabecular Bone Score (TBS) reflecting bone microarchitecture quality. It provides bone health assessment complementary to BMD measurements and optionally estimates 10-year fracture risk using the WHO FRAX tool, validated for patients aged 40-90 years. The software is used by physicians, radiologists, and DXA technicians in medical facilities to aid osteoporosis diagnosis and monitor treatment effects.

Technological characteristics

The primary advancement is replacement of BMI-based tissue thickness estimation with direct measurement of tissue thickness from DXA images. System architecture evolved from standalone software to a two-component system with a TBS Agent (client) on each DXA device and centralized server managing results and DICOM-PACS communication. Data security was enhanced with encryption for data at rest and in transit, plus role-based access control, whereas the predicate had no encryption or access controls.

Test standards cited

Not stated in this summary.

Substantial equivalence argument

TBS iNsight V4 maintains identical core functionality to its predicate (computing TBS from DXA image texture and providing complementary DXA analysis) with the same indications for use, regulatory class (II), product code (KGI), and target populations. Validation studies demonstrate the direct tissue thickness measurement algorithm produces correlation coefficients exceeding 0.99 with the predicate on cadaver specimens, meets or exceeds ISCD precision standards in 132 in vivo participants across multiple DXA systems, and achieves statistical equivalence in fracture risk assessment across 17,000 individuals in 14 international cohorts. The architectural and security improvements do not alter the device's fundamental diagnostic functionality or performance.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →